Long-term management is critical to reducing your risk of an anti-AQP4 antibody-positive NMOSD attack
Anti-AQP4, anti-aquaporin-4; NMOSD, neuromyelitis optica spectrum disorder.
NMOSD is a chronic condition, so it’s crucial to treat it even when you’re not actively having an attack
Every anti-AQP4 antibody-positive NMOSD attack puts you at risk for further damage and may result in additional disability over time
Choosing an appropriate treatment that fights anti-AQP4 antibody-positive NMOSD where the damage happens may help prevent future attacks
Treatments may have important limitations
Treatment is essential, but not all treatments work the same way.
Talk to your doctor to understand how to tell anti-AQP4 antibody-positive NMOSD symptoms and side effects apart.